Invention:
This technology presents an organophotocatalytic method for selective deuteration of metabolically labile α-positions in amides, amines, and secondary alcohols. This approach achieves high regioselectivity and deuterium incorporation by masking secondary amines as carbamates and employing a photoredox-HAT (hydrogen atom transfer) process. This innovation allows for efficient H/D exchange in complex pharmaceutical structures, including piperidine and piperazine, which are critical for enhancing drug stability and reducing metabolic degradation.
Background:
Current methods for α-deuteration of amides and amines are limited by the structural complexity of these compounds and the challenges in achieving selective deuteration at specific sites. Existing techniques, like iridium-catalyzed methods, often require complex steps and do not consistently yield high levels of deuteration. This new photoredox approach simplifies the process and improves efficiency by enabling precise deuterium incorporation under mild conditions.
Applications:
- Pharmaceutical drug design (metabolically stable amines and amides)
- Late-stage modification of drug candidates
- Drug metabolism and mechanism research
Advantages:
- High regioselectivity and deuterium incorporation (up to 100%)
- Efficient and mild protocol using readily available D2O
- Applicability to a range of structures, including 'privileged' pharmaceutical scaffolds like piperidine and piperazine
